{{Rsnum
|rsid=4837240
|Gene=LOC100289019
|Chromosome=9
|position=128111149
|Orientation=plus
|GMAF=0.2801
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=RP11-395P17.3
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 2.7 | 25.7 | 71.7
| HCB | 3.7 | 23.5 | 72.8
| JPT | 6.2 | 34.5 | 59.3
| YRI | 41.5 | 49.7 | 8.8
| ASW | 24.6 | 50.9 | 24.6
| CHB | 3.7 | 23.5 | 72.8
| CHD | 1.8 | 22.9 | 75.2
| GIH | 11.9 | 46.5 | 41.6
| LWK | 59.1 | 35.5 | 5.5
| MEX | 3.4 | 31.0 | 65.5
| MKK | 28.8 | 51.3 | 19.9
| TSI | 2.0 | 30.4 | 67.6
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19371221
|Title=Association analysis between the prostaglandin E synthase 2 R298H polymorphism and body mass index in 8079 participants of the KORA study cohort
}}

{{PMID Auto
|PMID=17566096
|Title=Association of prostaglandin E synthase 2 (PTGES2) Arg298His polymorphism with type 2 diabetes in two German study populations.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}